Sanofi
SNYNF
$84.97
-$1.67-1.93%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 17.82% | 12.21% | 6.95% | |
| Total Other Revenue | -- | -10.43% | -9.33% | -1.47% | |
| Total Revenue | -- | 15.33% | 10.40% | 6.29% | |
| Cost of Revenue | -- | 6.50% | 2.12% | 2.88% | |
| Gross Profit | -- | 19.30% | 14.19% | 7.81% | |
| SG&A Expenses | -- | 15.74% | 7.13% | 1.08% | |
| Depreciation & Amortization | -- | -9.03% | -15.24% | -10.04% | |
| Other Operating Expenses | -- | 12.10% | -1.32% | -8.99% | |
| Total Operating Expenses | -- | 10.63% | 3.77% | 2.06% | |
| Operating Income | -- | 37.82% | 44.47% | 26.27% | |
| Income Before Tax | -- | 82.69% | 62.80% | 9.23% | |
| Income Tax Expenses | -- | 130.70% | 135.52% | 17.21% | |
| Earnings from Continuing Operations | -- | 74.07% | 51.03% | 7.63% | |
| Earnings from Discontinued Operations | -- | 1,326.51% | -55.27% | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -142.65% | -84.47% | -59.43% | |
| Net Income | -- | 120.10% | 35.77% | 1.61% | |
| EBIT | -- | 37.82% | 44.47% | 26.27% | |
| EBITDA | -- | 29.76% | 32.11% | 25.23% | |
| EPS Basic | -- | 123.53% | 36.33% | 1.60% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | 123.91% | 36.25% | 1.50% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -0.95% | -0.33% | -0.04% | |
| Average Diluted Shares Outstanding | -- | -1.04% | -0.24% | 0.04% | |
| Dividend Per Share | -- | 3.23% | 3.23% | 3.23% | |
| Payout Ratio | -- | -- | -- | -- | |